These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 22368262)

  • 21. Spectral Domain Optical Coherence Tomography Reveals Hidden Fovea Beneath Extensive Vitreous Seeding From Retinoblastoma.
    Hasanreisoglu M; Dolz-Marco R; Ferenczy SR; Shields JA; Shields CL
    Retina; 2015 Jul; 35(7):1486-7. PubMed ID: 25756924
    [No Abstract]   [Full Text] [Related]  

  • 22. Ocular toxicity of intravitreal melphalan for retinoblastoma in Chinese patients.
    Xue K; Ren H; Meng F; Zhang R; Qian J
    BMC Ophthalmol; 2019 Feb; 19(1):61. PubMed ID: 30808420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravitreal chemotherapy in the management of vitreous disease in retinoblastoma.
    Kiratli H; Koç İ; Varan A; Akyüz C
    Eur J Ophthalmol; 2017 Jun; 27(4):423-427. PubMed ID: 28106239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan era.
    Berry JL; Shah S; Bechtold M; Zolfaghari E; Jubran R; Kim JW
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28646513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravitreal topotecan in the management of refractory and recurrent vitreous seeds in retinoblastoma.
    Rao R; Honavar SG; Sharma V; Reddy VAP
    Br J Ophthalmol; 2018 Apr; 102(4):490-495. PubMed ID: 28844050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis.
    Zhao J; Dimaras H; Massey C; Xu X; Huang D; Li B; Chan HS; Gallie BL
    J Clin Oncol; 2011 Mar; 29(7):845-51. PubMed ID: 21282531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating the risk of extraocular tumour spread following intravitreal injection therapy for retinoblastoma: a systematic review.
    Smith SJ; Smith BD
    Br J Ophthalmol; 2013 Oct; 97(10):1231-6. PubMed ID: 23740960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravitreal injection of melphalan for intraocular retinoblastoma.
    Suzuki S; Aihara Y; Fujiwara M; Sano S; Kaneko A
    Jpn J Ophthalmol; 2015 May; 59(3):164-72. PubMed ID: 25808017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathological findings in enucleated eyes after intravitreal melphalan injection.
    Ghassemi F; Amoli FA
    Int Ophthalmol; 2014 Jun; 34(3):533-40. PubMed ID: 24043335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization after superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastoma.
    Munier FL; Beck-Popovic M; Balmer A; Gaillard MC; Bovey E; Binaghi S
    Retina; 2011 Mar; 31(3):566-73. PubMed ID: 21273941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Short-term efficacy of intravitreal injection of melphalan for refractory vitreous seeding from retinoblastoma].
    Xue K; Ren H; Zhang R; Yuan YF; Qian J
    Zhonghua Yan Ke Za Zhi; 2017 Aug; 53(8):570-574. PubMed ID: 28851196
    [No Abstract]   [Full Text] [Related]  

  • 32. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
    Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
    Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravitreal melphalan hydrochloride vs propylene glycol-free melphalan for retinoblastoma vitreous seeds: Efficacy, toxicity and stability in rabbits models and patients.
    Bogan CM; Pierce JM; Doss SD; Tao YK; Chen SC; Boyd KL; Liao A; Hsieh T; Abramson DH; Francis JH; Friedman DL; Richmond A; Daniels AB
    Exp Eye Res; 2021 Mar; 204():108439. PubMed ID: 33444583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma.
    Schaiquevich P; Ceciliano A; Millan N; Taich P; Villasante F; Fandino AC; Dominguez J; Chantada GL
    Pediatr Blood Cancer; 2013 May; 60(5):766-70. PubMed ID: 23024125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eye-preservation treatment of retinoblastoma with vitreous seeding.
    Kaneko A; Suzuki S
    Jpn J Clin Oncol; 2003 Dec; 33(12):601-7. PubMed ID: 14769836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravitreal injection of melphalan in the treatment of retinoblastoma with vitreous cavity seeding.
    Sun YB; Hui P; Punyara K; Bi MC; Li SH; Teng SY; Song E
    Chin Med J (Engl); 2013; 126(8):1587. PubMed ID: 23595400
    [No Abstract]   [Full Text] [Related]  

  • 37. A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma.
    Abramson DH; Frank CM; Dunkel IJ
    Ophthalmology; 1999 Oct; 106(10):1947-50. PubMed ID: 10519590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intra-Arterial Chemotherapy for Retinoblastoma: A Single-Center Experience.
    Akyüz C; Kıratlı H; Şen H; Aydın B; Tarlan B; Varan A
    Ophthalmologica; 2015; 234(4):227-32. PubMed ID: 26368674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience.
    Gobin YP; Dunkel IJ; Marr BP; Brodie SE; Abramson DH
    Arch Ophthalmol; 2011 Jun; 129(6):732-7. PubMed ID: 21320950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience.
    Francis JH; Brodie SE; Marr B; Zabor EC; Mondesire-Crump I; Abramson DH
    Ophthalmology; 2017 Apr; 124(4):488-495. PubMed ID: 28089679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.